Keywords: pharma, stocks, rally, relief, bush, win, pressures
US pharma stocks' "rally relief" on Bush win but pressures remain, analysts warn
Article | 15 November 2004
US markets saw pharmaceutical stocks experience "rally relief" following President George W Bush's re-election (Marketletter November 8 and page 15 this issue), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
